Vitamin D, menopause, and aging: quo vadis? Climacteric.
Vitamin D, menopause, and aging: quo vadis? Climacteric.
Prevalence and mortality of individuals with X-linked hypophosphataemia: a United Kingdom real world data analysis.
Prevalence and mortality of individuals with X-linked hypophosphataemia: a United Kingdom real world data analysis.
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Bone Mineral Metabolism Status, Quality of Life, and Muscle Strength in Older People. Nutrients.
Bone Mineral Metabolism Status, Quality of Life, and Muscle Strength in Older People. Nutrients.
Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.
Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.
A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis.
A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis.
Smoking and Alcohol Intake but Not Muscle Strength in Young Men Increase Fracture Risk at Middle Age: A Cohort Study Linked to the Swedish National Patient Registry.
Smoking and Alcohol Intake but Not Muscle Strength in Young Men Increase Fracture Risk at Middle Age: A Cohort Study Linked to the Swedish National Patient Registry.
Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: Apractice-level prescribing data analysis in 2013-2018.
Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: Apractice-level prescribing data analysis in 2013-2018.
Targeting Macrophages: Friends or Foes in Disease? Front Pharmacol.
Targeting Macrophages: Friends or Foes in Disease? Front Pharmacol.
Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep.
Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep.
